HDGFL2 and infection: Analytical benchmarking and clinical sensitivity modeling for these tests indicate that they have improved LODs for LDH that may result in higher clinical performance in terms of sensitivity toward Pf infections with hrp2/hrp3 gene deletions and for Pv clinical infections [20].